(Natural News)—A controversial new preprint study has raised alarm by presenting what its authors describe as the first direct evidence that genetic fragments from mRNA COVID-19 vaccines may integrate into human DNA, potentially triggering aggressive cancer development. Published on Zenodo, an online research repository operated by CERN, the study focused on a 31-year-old woman who developed rapidly progressive stage IV bladder cancer within a year of receiving three Moderna vaccine doses.
- Preprint case report of genomic integration — A new preprint describes a previously healthy 31-year-old woman with rapidly progressive stage-IV bladder cancer and reports molecular evidence the authors interpret as vaccine-derived genetic material integrated into her tumor DNA.
- 100 percent sequence match and alleged oncogenic context — The team reports a DNA fragment that matches a spike-protein sequence found in mRNA COVID-19 vaccines, and says this integration occurred in a gene-dense, unstable region alongside widespread cancer-associated mutations and dysregulated pathways.
- Proposed mechanisms and prior contamination findings — The authors point to possible causes (residual plasmid DNA carry-over during manufacturing, reverse transcription of spike mRNA, or indirect genomic instability) and cite earlier studies that reported DNA contamination in mRNA vaccine lots.
- Single preprint, authors call for urgent study and action — The paper’s authors argue the signal “cannot be ignored” and urge regulatory review or suspension but also note causality cannot be proven from one case and say further investigation is needed.
COVID vaccine genetic ‘fingerprint’ found in 31-year-old cancer patient’s DNA
The patient, previously healthy and with no personal or family history of cancer, was diagnosed with an unusually aggressive form of bladder cancer typically seen in people over 70. Researchers conducted an extensive molecular analysis, including tumor DNA sequencing, transcriptome profiling, and protein analysis. Their tests revealed a genetic fragment embedded in her genome that matched 100 percent with a nucleotide sequence from the spike protein region of the Pfizer-BioNTech vaccine.
Although the woman received only Moderna shots, both mRNA vaccines share identical genetic stretches in the spike protein. Moderna’s proprietary plasmid sequence has not been publicly deposited, leading researchers to identify Pfizer’s vaccine as the closest known match. The probability of a random match of this kind was estimated at roughly one in a trillion.
Study co-author Nicolas Hulscher described the findings as a “perfect storm,” where cancer-driving genes were activated, DNA-repair genes disabled, and broad cellular disruption occurred. He argued this pattern is biologically plausible for accelerating cancer progression.
Broader concerns about DNA contamination
The study links its findings to broader debates about DNA contamination in mRNA vaccines. Residual DNA fragments, left from the manufacturing process, may survive encapsulation in lipid nanoparticles, potentially entering cells and integrating into the genome. Previous studies have confirmed the presence of billions of plasmid DNA fragments per dose in Pfizer and Moderna vaccines, with contamination levels sometimes hundreds of times above regulatory limits.
Critics argue such contamination could contribute to turbo cancer, chronic inflammation, blood clots, strokes, and other serious conditions. Karl Jablonowski of Children’s Health Defense emphasized that regulators initially dismissed such risks, assuming DNA fragments would be degraded. The new findings, he said, suggest otherwise and demand a reassessment of vaccine safety.
Bladder cancer in women under 35 is extremely rare, accounting for less than 0.5% of cases, and advanced stage IV cancer is considered an “extreme outlier.” Study co-author John A. Catanzaro stressed that the rarity of this case made it worthy of deep investigation. The patient remains alive under ongoing treatment with targeted therapies, but her disease progression underscores the unusual nature of the case.
Implications and calls for action
While the authors acknowledge that causality cannot be confirmed from a single case, they argue the convergence of DNA integration, oncogenic disruptions, and rare cancer presentation represents a highly unusual and biologically plausible pattern. Hulscher and colleagues call for urgent follow-up studies, precautionary suspension of mRNA vaccines, and stronger informed consent regarding cancer risks.
“Before now, integration was dismissed as impossible,” Hulscher said. “Our findings demonstrate it can happen, in a dangerous region of the genome, with clear functional consequences. Humanity cannot gamble with genomic disruption.”
Bookmark Infections.news to get the latest updates about where pandemics really start, who pushes the propaganda, and why you should avoid the deadly vaccines they falsely claim are “safe and effective.”
Sources for this article include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.